Skip to main content

US BANCORP \DE\

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,348,416
+$66,855 QoQ
Shares Held
5,628
+1.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 45.18479033404407.ToString("F0")% Shared 0.30206112295664533.ToString("F0")% None 54.51314854299929.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

US BANCORP \DE\ holds $76,267,286 across 226 Biotechnology names. REGN ranks #4 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
5,628 $4,348,416

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,348,416 5,628
2025-12-31 $4,281,561 5,547
2025-09-30 $3,206,061 5,702
2025-06-30 $2,880,675 5,487
2025-03-31 $4,024,187 6,345
2024-12-31 $4,320,990 6,066
2024-09-30 $5,243,583 4,988
2024-06-30 $5,426,466 5,163
2024-03-31 $4,822,072 5,010
2023-12-31 $4,339,628 4,941
2023-09-30 $3,811,126 4,631
2023-06-30 $3,285,163 4,572
2023-03-31 $4,197,089 5,108
2022-12-31 $3,564,159 4,940
2022-09-30 $3,983,734 5,783
2022-06-30 $3,374,760 5,709
2022-03-31 $4,189,122 5,998
2021-12-31 $3,764,489 5,961
2021-09-30 $3,585,085 5,924
2021-06-30 $3,413,236 6,111
2021-03-31 $2,847,356 6,018
2020-12-31 $2,604,927 5,392
2020-09-30 $2,553,154 4,561
2020-06-30 $2,032,474 3,259
2020-03-31 $1,714,384 3,511